Comparison

BCL2 Blocking Peptide (Center)

Item no. ABC-BP19821c
Manufacturer Abcepta
Amount 500 ug
Category
Type Peptides
Format Lyophilized
Specific against other
Citations Feng, H., et al. Cancer Cell 18(4):353-366(2010)
Azad, N., et al. Ann. N. Y. Acad. Sci. 1203, 1-6 (2010):
Dubikov, A.I., et al. Scand. J. Rheumatol. 39(5):368-372(2010)
Yu, B., et al. J. Exp. Clin. Cancer Res. 29, 107 (2010):
Trisciuoglio, D., et al. PLoS ONE 5 (7), E11772 (2010) :
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias Apoptosis regulator Bcl-2,BCL2
Similar products BCL2, Apoptosis regulator Bcl-2
Available
Manufacturer - Category
Peptides; Blocking Peptides
Manufacturer - Targets
The synthetic peptide sequence is selected from aa 102-116 of HUMAN BCL2
Bio Background
This gene encodes an integral outer mitochondrial membraneprotein that blocks the apoptotic death of some cells such aslymphocytes. Constitutive expression of BCL2, such as in the caseof translocation of BCL2 to Ig heavy chain locus, is thought to bethe cause of follicular lymphoma. Two transcript variants, producedby alternate splicing, differ in their C-terminal ends. [providedby RefSeq].
Gene Name
BCL2
Subtitle
Synthetic peptide
Formulation
Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 500 ug
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close